open access

Vol 66, No 1 (2015)
Original paper
Submitted: 2014-02-26
Accepted: 2014-06-05
Published online: 2015-03-02
Get Citation

Ectopic Cushing’s syndrome secondary to lung and mediastinal tumours — report from a tertiary care centre in Iran

Ali A. Ghazi, Azizollah Abbasi Dezfooli, Alireza Amirbaigloo, Abolghasem Daneshvar Kakhki, Farzaneh Mohammadi, Farrokh Tirgari, Marina Pourafkari
DOI: 10.5603/EP.2015.0002
·
Pubmed: 25754275
·
Endokrynol Pol 2015;66(1):2-9.

open access

Vol 66, No 1 (2015)
Original Paper
Submitted: 2014-02-26
Accepted: 2014-06-05
Published online: 2015-03-02

Abstract

Introduction: Ectopic Cushing`s syndrome (ECS) secondary to neuroendocrine tumours (NETs) of the lung and mediastinum are rarely encountered. In this study, we present our experience in Iran on 15 patients with ECS secondary to lung and mediastinal tumours over a period of 27 years.

Material and methods: Since 1985, 15 patients with ECS secondary to lung and mediastinal tumours have been diagnosed and prospectively followed by the endocrinology team of Taleghani Hospital, Tehran, Iran. The clinical signs and symptoms, laboratory findings, radiological features, immunohistochemical characteristics, management strategies and outcome data are here presented.

Results: There were six women and nine men, aged 26–70 years, all presenting with typical features of Cushing’s syndrome. Based on histopathologic evaluations, four patients had small cell lung cancer (SCLC) and seven patients had pulmonary NETs, one patient had a thymic NET, and one case was diagnosed as a lung tumourlet. The mean ± SD serum cortisol, 24h urine free cortisol and plasma ACTH were 47.2 ± 20.5 μg/dL, 2,702 ± 5,439 μg/day, and 220 ± 147 pg/mL, respectively. Pulmonary lesions ranged in diameter from 1.1 to 4 cm (mean 1.9 ± 1.1 cm). One patient had a 10 cm mediastinal mass. The duration of follow up in these cases was between one month and seven years (mean 29.9 ± 27.5 months). The four patients with SCLC died within three months of diagnosis.

Conclusion: Our data demonstrates the protean clinical and laboratory manifestations of ECS secondary to lung and mediastinal tumours, the problems encountered in diagnosis, and the need for a multidisciplinary approach. This study confirms other series from Western Europe and North America that, unlike the SCLC patients who show a poor outlook, ECS secondary to lung carcinoids has a more favourable prognosis.

Abstract

Introduction: Ectopic Cushing`s syndrome (ECS) secondary to neuroendocrine tumours (NETs) of the lung and mediastinum are rarely encountered. In this study, we present our experience in Iran on 15 patients with ECS secondary to lung and mediastinal tumours over a period of 27 years.

Material and methods: Since 1985, 15 patients with ECS secondary to lung and mediastinal tumours have been diagnosed and prospectively followed by the endocrinology team of Taleghani Hospital, Tehran, Iran. The clinical signs and symptoms, laboratory findings, radiological features, immunohistochemical characteristics, management strategies and outcome data are here presented.

Results: There were six women and nine men, aged 26–70 years, all presenting with typical features of Cushing’s syndrome. Based on histopathologic evaluations, four patients had small cell lung cancer (SCLC) and seven patients had pulmonary NETs, one patient had a thymic NET, and one case was diagnosed as a lung tumourlet. The mean ± SD serum cortisol, 24h urine free cortisol and plasma ACTH were 47.2 ± 20.5 μg/dL, 2,702 ± 5,439 μg/day, and 220 ± 147 pg/mL, respectively. Pulmonary lesions ranged in diameter from 1.1 to 4 cm (mean 1.9 ± 1.1 cm). One patient had a 10 cm mediastinal mass. The duration of follow up in these cases was between one month and seven years (mean 29.9 ± 27.5 months). The four patients with SCLC died within three months of diagnosis.

Conclusion: Our data demonstrates the protean clinical and laboratory manifestations of ECS secondary to lung and mediastinal tumours, the problems encountered in diagnosis, and the need for a multidisciplinary approach. This study confirms other series from Western Europe and North America that, unlike the SCLC patients who show a poor outlook, ECS secondary to lung carcinoids has a more favourable prognosis.

Get Citation

Keywords

ectopic Cushing’s syndrome; mediastinum; lung; carcinoid; carcinoma

About this article
Title

Ectopic Cushing’s syndrome secondary to lung and mediastinal tumours — report from a tertiary care centre in Iran

Journal

Endokrynologia Polska

Issue

Vol 66, No 1 (2015)

Article type

Original paper

Pages

2-9

Published online

2015-03-02

Page views

2252

Article views/downloads

2166

DOI

10.5603/EP.2015.0002

Pubmed

25754275

Bibliographic record

Endokrynol Pol 2015;66(1):2-9.

Keywords

ectopic Cushing’s syndrome
mediastinum
lung
carcinoid
carcinoma

Authors

Ali A. Ghazi
Azizollah Abbasi Dezfooli
Alireza Amirbaigloo
Abolghasem Daneshvar Kakhki
Farzaneh Mohammadi
Farrokh Tirgari
Marina Pourafkari

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl